Advances in I-O Biomarkers

While the rapid evolution of I-O continues to bring unprecedented change to the way cancer is treated, there are significant gaps impacting the laboratory team regarding the examination of resection specimens following neoadjuvant immunotherapy and staying abreast of advances in I-O biomarker testing. This episode discusses advances in I-O biomarker testing, advantages and limitations of some key I-O biomarkers, and practical ways that pathologists and laboratory professionals can improv...